Molly Henderson, Chief Financial Officer at UroGen Pharma Ltd. (URGN), bought 2,500 shares at $15.85 ($40K) on 2021-05-17, disclosed to the SEC on 2021-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |